PTHS

Pelthos Therapeutics Inc.$27.51+2.11 (+8.31%)

Prev Close$25.40·MCap$15.4M·P/E—·Vol32.0K·Yield—

▲

Buys (12M)

$1000.0K

▼

Sells (12M)

$441.3K

◆

Net Activity

Net Buyer

$558.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Pelthos Therapeutics Inc. (PTHS) has been dominated by buying, with 1 insider purchase totaling $1000.0K and 10 insider sales totaling $441.3K. The most recent insider transaction was by Pauls Matthew (director), who sold $20.6K worth of shares on Jul 7, 2026. Pelthos Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $15.4M.

PTHS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 7, 2026	Pauls Matthew	director	Sell	786	$26.16	$20.6K	14,458
Jul 7, 2026	Greenleaf Peter	director	Sell	797	$26.13	$20.8K	23,969
Jul 7, 2026	Friedberg Ezra M	director	Sell	558	$26.09	$14.6K	81,066
Jun 17, 2026	Friedberg Ezra M	director	Sell	283	$27.29	$7.7K	81,659
Jun 15, 2026	Davis Todd C	director	Buy	35,948	$27.82	$1000.0K5.5% OS	75,834+90%
May 26, 2026	Francis Knuettel II	officer: CFO, Treas & Secty	Sell	1,500	$26.84	$40.3K	11,316
Apr 6, 2026	Friedberg Ezra M	director	Sell	558	$20.92	$11.7K	82,292
Apr 6, 2026	Greenleaf Peter	director	Sell	797	$20.92	$16.7K	25,058
Apr 6, 2026	Malamut Richard	director	Sell	590	$20.92	$12.3K	27,702
Apr 6, 2026	Pauls Matthew	director	Sell	786	$20.92	$16.4K	15,521
Nov 25, 2025	Friedberg Ezra M	Director	Sell	10,000	$28.03	$280.3K1.5% OS	0
Sep 16, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	5,200	$0.97	$5.0K0.8% OS	547,710
Sep 16, 2024	Malamut Richard	Director	Buy	10,400	$0.94	$9.8K1.6% OS	91,565
Sep 12, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	12,000	$0.91	$11.0K1.9% OS	542,510

PTHS Insider Buying Activity

The following table shows recent insider purchases of Pelthos Therapeutics Inc. (PTHS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 15, 2026	Davis Todd C	director	Buy	35,948	$27.82	$1000.0K5.5% OS	75,834+90%
Sep 16, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	5,200	$0.97	$5.0K0.8% OS	547,710
Sep 16, 2024	Malamut Richard	Director	Buy	10,400	$0.94	$9.8K1.6% OS	91,565
Sep 12, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	12,000	$0.91	$11.0K1.9% OS	542,510

PTHS Insider Selling Activity

The following table shows recent insider sales of Pelthos Therapeutics Inc. (PTHS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 7, 2026	Pauls Matthew	director	Sell	786	$26.16	$20.6K	14,458
Jul 7, 2026	Greenleaf Peter	director	Sell	797	$26.13	$20.8K	23,969
Jul 7, 2026	Friedberg Ezra M	director	Sell	558	$26.09	$14.6K	81,066
Jun 17, 2026	Friedberg Ezra M	director	Sell	283	$27.29	$7.7K	81,659
May 26, 2026	Francis Knuettel II	officer: CFO, Treas & Secty	Sell	1,500	$26.84	$40.3K	11,316
Apr 6, 2026	Friedberg Ezra M	director	Sell	558	$20.92	$11.7K	82,292
Apr 6, 2026	Greenleaf Peter	director	Sell	797	$20.92	$16.7K	25,058
Apr 6, 2026	Malamut Richard	director	Sell	590	$20.92	$12.3K	27,702
Apr 6, 2026	Pauls Matthew	director	Sell	786	$20.92	$16.4K	15,521
Nov 25, 2025	Friedberg Ezra M	Director	Sell	10,000	$28.03	$280.3K1.5% OS	0